Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Last Updated on: 24 February, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Laurus Labs Ltd

About the Company - Laurus Labs Ltd

Laurus Labs Ltd. is a Public Limited Listed company incorporated on 19/09/2005 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24239AP2005PLC047518 and registration number is 047518. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 4707.04 Cr. and Equity Capital is Rs. 107.47 Cr. for the Year ended 31/03/2022.
PharmaceuticalsLaurus Enclave, Plot Office 01, Edulapakabonangi Village, Vishakapatnam Andhra Pradesh
NamePosition Held
Dr. M Venu Gopala RaoNon Exe.Chairman&Ind.Director
Dr. C V Lakshmana RaoExecutive Director
Dr. Satyanarayana ChavaExecutive Director & CEO
Mr. V V Ravi KumarExecutive Director & CFO
Dr. Ravindranath KancherlaIndependent Director
Mrs. Aruna Rajendra BhingeIndependent Director
Dr. Rajesh Koshy ChandyIndependent Director
Mr. Chandrakanth ChereddiNon Executive Director

Laurus Labs Ltd. Share Price Update

Share PriceValue
Previous Day₹391.20

Basic Stock Data of Laurus Labs Ltd

Market Cap 21,480 Cr.
Current Price 399
High / Low445/279
Stock P/E105
Book Value 75.2
Dividend Yield0.50 %
ROCE22.2 %
ROE20.4 %
Face Value 2.00

Data Source:

Laurus Labs Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Operating Profit415462363334215373418426385252128181170
OPM %33%33%30%28%23%27%28%28%26%20%12%16%15%
Other Income96847234367611
Profit before tax357396290258142285328317270137176357
Tax %25%26%23%24%23%22%29%28%26%25%24%26%25%
Net Profit267293222198109221232227199102134743
EPS in Rs4.985.464.143.682.034.124.314.233.701.900.240.870.79

Laurus Labs Ltd Quarterly Chart

Laurus Labs Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Operating Profit781452092053724144093525711,5111,2861,482946
OPM %17%20%18%15%21%22%20%16%20%32%27%26%19%
Other Income159344322815526201622
Profit before tax2286121721802452411213041,2759751,051488
Tax %0%-2%20%-2%19%18%28%22%12%25%23%28%
Net Profit2288977414520017395267956750760361
EPS in Rs2.8311.5812.649.4718.363.783.271.785.0017.8213.9614.126.71
Dividend Payout %0%0%0%0%2%8%9%17%10%11%14%14%

Laurus Labs Ltd Profit & Loss Yearly Chart

Laurus Labs Ltd Growth

Compounded Sales Growth
10 Years:23%
5 Years:23%
3 Years:27%
Compounded Profit Growth
10 Years:24%
5 Years:34%
3 Years:42%
Stock Price CAGR
10 Years:%
5 Years:42%
3 Years:4%
1 Year:18%
Return on Equity
10 Years:22%
5 Years:23%
3 Years:27%
Last Year:20%

Laurus Labs Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital1515151616106106106107107107108108
Preference Capital62626267670000000
Other Liabilities1812124344114095095477188721,5021,5671,1871,461
Total Liabilities5137011,2731,8932,2292,6733,0083,3183,7395,6256,6096,9587,322
Fixed Assets1872364998011,0141,1931,4481,5991,6941,8182,1862,8843,001
Other Assets2943936589661,1191,2861,3451,5541,9203,1643,3063,3333,657
Total Assets5137011,2731,8932,2292,6733,0083,3183,7395,6256,6096,9587,322

Laurus Labs Ltd Reserves and Borrowings Chart

Laurus Labs Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 3988121-59197321369293345694823882
Cash from Investing Activity -46-124-312-406-315-282-417-257-217-900-837-735
Cash from Financing Activity 113420348690-4749-37-12724315-185
Net Cash Flow4-21221-27-80-00382-39

Laurus Labs Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days12080617891108100112102989894
Inventory Days136138165210177184199201233257279211
Days Payable1331171141019111010614415719414090
Cash Conversion Cycle123101112187177183193169177161237216
Working Capital Days1209348119117126124116119127140138
ROCE %17%27%25%15%17%17%14%8%14%38%23%22%

Laurus Labs Ltd Financial Efficiency Indicators Chart

Laurus Labs Ltd Share Holding Pattern

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
No. of Shareholders2,12,5722,35,8362,99,2573,94,0534,67,4194,27,4654,07,1863,90,6954,23,9314,18,6154,17,9774,02,640

Laurus Labs Ltd Shareholding Pattern Chart

No. of Laurus Labs Ltd Shareholders

Laurus Labs Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Mirae Asset Midcap Fund41100341.26148.68
Kotak Emerging Equity Fund - Regular Plan28289620.3102.34
PGIM India Midcap Opportunities Fund25300001.0191.52
Franklin India Prima Fund24223581.0387.63
Sundaram Mid Cap Fund21196990.976.68
Sundaram Mid Cap Fund - Institutional Plan21196990.976.68
Bandhan Sterling Value Fund17000000.9261.5
Bandhan ELSS Tax Saver Fund16000001.1557.88
Axis Small Cap Fund15899770.3557.52
Franklin India Equity Advantage Fund11000001.4339.79

Laurus Labs Ltd ROCE Trend

Laurus Labs Ltd EPS Trend

Laurus Labs Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
Basic EPS (Rs.)14.6915.4218.3623.938.83
Diluted EPS (Rs.)14.6415.4218.2823.938.80
Cash EPS (Rs.)20.8120.1722.1641.3924.23
Book Value[Excl.RevalReserv]/Share (Rs.)75.1662.5148.47165.53146.41
Book Value[Incl.RevalReserv]/Share (Rs.)75.1662.5148.47165.53146.41
Revenue From Operations / Share (Rs.)112.1491.8589.70264.86215.33
PBDIT / Share (Rs.)29.6726.7229.3453.3634.88
PBIT / Share (Rs.)23.6522.0425.5235.8419.45
PBT / Share (Rs.)20.5920.1724.2527.4611.25
Net Profit / Share (Rs.)14.7915.4918.3323.888.81
NP After MI And SOA / Share (Rs.)14.6715.4018.3323.888.81
PBDIT Margin (%)26.4529.0932.7020.1416.19
PBIT Margin (%)21.0923.9928.4413.539.03
PBT Margin (%)18.3521.9527.0310.365.22
Net Profit Margin (%)13.1816.8620.439.014.09
NP After MI And SOA Margin (%)13.0816.7620.439.014.09
Return on Networth / Equity (%)19.5624.6937.8614.426.01
Return on Capital Employeed (%)24.3727.6341.5718.6210.85
Return On Assets (%)10.3111.8717.106.802.81
Long Term Debt / Equity (X)
Total Debt / Equity (X)0.480.510.500.530.60
Asset Turnover Ratio (%)0.820.761.020.790.70
Current Ratio (X)1.421.
Quick Ratio (X)0.730.590.610.530.54
Inventory Turnover Ratio (X)1.511.401.952.041.94
Dividend Payout Ratio (NP) (%)13.6010.377.6212.5316.96
Dividend Payout Ratio (CP) (%)9.647.956.317.236.16
Earning Retention Ratio (%)86.4089.6392.3887.4783.04
Cash Earning Retention Ratio (%)90.3692.0593.6992.7793.84
Interest Coverage Ratio (X)9.6814.2623.106.374.25
Interest Coverage Ratio (Post Tax) (X)5.829.2715.433.852.07
Enterprise Value (Cr.)17717.0933370.2920697.574402.845194.72
EV / Net Operating Revenue (X)2.936.764.301.552.27
EV / EBITDA (X)11.0923.2413.157.7213.99
MarketCap / Net Operating Revenue (X)2.616.424.041.221.86
Retention Ratios (%)86.3989.6292.3787.4683.03
Price / BV (X)3.919.467.481.952.73
Price / Net Operating Revenue (X)2.616.424.041.221.86

Laurus Labs Ltd Profitability Ratios (%)

Laurus Labs Ltd Liquidity Ratios

Laurus Labs Ltd Liquidity Ratios (%)

Laurus Labs Ltd Interest Coverage Ratios (%)

Laurus Labs Ltd Valuation Ratios

Fair Value of Laurus Labs Ltd Stock

Fair Value: ₹1618.84

The stock is undervalued by 305.72% compared to the current price ₹399

*Investments are subject to market risks

Strength and Weakness of Laurus Labs Ltd Stock

  1. The stock has a high average ROCE of 19.75%, which is a positive sign.
  2. The company has higher reserves (1,663.00 cr) compared to borrowings (24.62 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (92.15 cr) and profit (219.77 cr) over the years.
  1. The stock is trading at a high valuation with an average P/B ratio of 25.30 and average Dividend Yield of 19.22%.
  2. The stock has a high average Working Capital Days of 115.58, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 169.67, which may not be favorable.

About the Author

Author Avatar

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Laurus Labs Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE